Do you want to read an article? Please log in or register.
Adverse reactions in a large cohort of patients with inborn errors of immunity receiving intravenous immunoglobulin
Immunodeficiency
Related content
Further Publications Immunology
Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study
J Allergy Clin Immunol
Meyts I, Bucciol G, Quinti I, Neven B, Fischer A, Seoane E, Lopez-Granados E, Gianelli C, Robles-Marhuenda A, Jeandel PY, Paillard C, Sankaran VG, Demirdag YY, Lougaris V, Aiuti A, Plebani A, Milito C, Dalm VA, Guevara-Hoyer K, Sánchez-Ramón S, Bezrodnik L, Barzaghi F, Gonzalez-Granado LI, Hayman GR, Uzel G, Mendonça LO, Agostini C, Spadaro G, Badolato R, Soresina A, Vermeulen F, Bosteels C, Lambrecht BN, Keller M, Mustillo PJ, Abraham RS, Gupta S, Ozen A, Karakoc-Aydiner E, Baris S, Freeman A, Yamazaki-Nakashimada M, Scheffler-Mendoza S, Espinosa-Padilla S, Gennery AR, Jolles S, Espinoza Y, Poli MC, Fieschi C, Hauck F, Cunningham-Rundles C, Mahlaoui N, IUIS Committee of Inborn Errors of Immunity., Warnatz K, Sullivan KE, Tangye SG
doi: 10.1016/j.jaci.2020.09.010
Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology
Whole-Exome Sequencing-Based Approach for Germline Mutations in Patients with Inborn Errors of Immunity
J Clin Immunol.
Okano T, Imai K, Naruto T, Okada S, Yamashita M, Yeh TW, Ono S, Tanaka K, Okamoto K, Tanita K, Matsumoto K, Toyofuku E, Kumaki-Matsumoto E, Okamura M, Ueno H, Ogawa S, Ohara O, Takagi M, Kanegane H, Morio T
doi: 10.1007/s10875-020-00798-3.
Autoimmune Disease
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Lancet Neurol
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA, Dutch GBS Study Group.
doi: 10.1016/S1474-4422(20)30494-4
Immunodeficiency
TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity
Clin Exp Immunol.
Dasouki M, Jabr A, AlDakheel G, Elbadaoui F, Alazami AM, Al-Saud B, Arnaout R, Aldhekri H, Alotaibi I, Al-Mousa H, Hawwari A
doi: 10.1111/cei.13484.
Further Publications Immunology
Outcome of SARS-CoV-2 Infection in 121 Patients with Inborn Errors of Immunity: A Cross-Sectional Study
J Clin Immunol
Goudouris ES, Pinto-Mariz F, Mendonça LO, Aranda CS, Guimarães RR, Kokron C, Barros MT, Anísio F, Alonso MLO, Marcelino F, Valle SOR, Junior SD, Barreto IDP, Ferreira JFS, Roxo-Junior P, do Rego Silva AM, Campinhos FL, Bonfim C, Loth G, Fernandes JF, Garcia JL, Capelo A, Takano OA, Nadaf MIV, Toledo EC, Cunha LAO, Di Gesu RSW, Schidlowski L, Fillipo P, Bichuetti-Silva DC, Soldateli G, Ferraroni NR, de Oliveira Dantas E, Pestana S, Mansour E, Ulaf RG, Prando C, Condino-Neto A, Grumach AS
doi: 10.1007/s10875-021-01066-8
Autoimmune DiseaseImmunotherapy
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Preexisting Autoimmune Disease: A Nationwide Multicenter Cohort Study
Arthritis Rheumatol.
Tison A, Quéré G, Misery L, Funck-Brentano E, Danlos FX, Routier E, Robert C, Loriot Y, Lambotte O, Bonniaud B, Scalbert C, Maanaoui S, Lesimple T, Martinez S, Marcq M, Chouaid C, Dubos C, Brunet-Possenti F, Stavris C, Chiche L, Beneton N, Mansard S, Guisier F, Doubre H, Skowron F, Aubin F, Zehou O, Roge C, Lambert M, Pham-Ledard A, Beylot-Barry M, Veillon R, Kramkimel N, Giacchero D, Quatrebarbes J, Michel C, Auliac JB, Gonzales G, Decroisette C, Le Garff G, Carpiuc I, Vallerand H, Nowak E, Cornec D, Kostine M, Groupe de Cancérologie Cutanée (GCC), Groupe Français de Pneumo-Cancérologie (GFPC), Club Rhumatismes et Inflammations (CRI).
doi: 10.1002/art.41068.
Immunodeficiency
Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study
Clin Immunol.
Legendre P, Chahwan D, Marjanovic Z, Vignon M, Hermine O, Lortholary O, Morelle G, Darrodes M, Kahn JE, Ouzegdouh M, Chaibi P, Montestruc F, Caumont-Prim A, Le Jouan M, Hassani Y, Godeau B, Durand-Zaleski I, Mouthon L
doi: 10.1016/j.clim.2020.108419.
Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology
Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients
Arthritis Res Ther.
Campanilho-Marques R, Deakin CT, Simou S, Papadopoulou C, Wedderburn LR, Pilkington CA, Juvenile Dermatomyositis Research Group (JDRG).
doi: 10.1186/s13075-020-02164-5.
Vitiligo
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study
Drug Saf.
Babai S, Voisin AL, Bertin C, Gouverneur A, Le-Louet H
doi: 10.1007/s40264-019-00875-6.